everolimus

NDC 82293-031 · Novugen Pharma (USA) LLC.

Generic nameeverolimus

Dosage formTABLET

RouteORAL

Active ingredient(s)EVEROLIMUS

Strength5 mg/1

Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]

Marketing categoryANDA

Packages

82293-031-10 — 28 TABLET in 1 BOTTLE (82293-031-10)

82293-031-21 — 4 BLISTER PACK in 1 CARTON (82293-031-21) / 7 TABLET in 1 BLISTER PACK (82293-031-20)

82293-031-31 — 1 POUCH in 1 CARTON (82293-031-31) / 3 BLISTER PACK in 1 POUCH / 10 TABLET in 1 BLISTER PACK (82293-031-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70377-012 — everolimus, 70377-013 — everolimus, 70377-069 — Everolimus, 70377-070 — EVEROLIMUS, 70377-071 — everolimus, 70377-090 — Everolimus, 70377-091 — Everolimus, 70377-092 — Everolimus, 70377-112 — everolimus, 72603-254 — everolimus, 72603-255 — everolimus, 72603-256 — everolimus, 72603-257 — everolimus, 82249-610 — Everolimus, 82249-611 — Everolimus, 82249-612 — Everolimus, 82249-613 — Everolimus, 82293-030 — everolimus, 82293-032 — everolimus, 82293-033 — everolimus, +63 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.